ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session

October 23, 1998

House Still Sees Problems In NIH Financial Management

July 5, 1991

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

Slamon, Sherr Win Landon-AACR Prizes

March 7, 2003

In Brief: NCAB Approves Concept Of Converting Baltimore Program To Cancer Center; New DCCP Labs Named

June 5, 1981

FDA Approves Afinitor Tablets For Advanced Breast Cancer

August 31, 2012